Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Merck
Moodys
McKinsey
Baxter

Last Updated: October 17, 2019

DrugPatentWatch Database Preview

Vistapharm Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for VISTAPHARM, and what generic and branded alternatives to VISTAPHARM drugs are available?

VISTAPHARM has twenty approved drugs.



Summary for Vistapharm
US Patents:0
Tradenames:14
Ingredients:14
NDAs:20
Patent Litigation for Vistapharm: See patent lawsuits for Vistapharm

Drugs and US Patents for Vistapharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vistapharm MYCOPHENOLATE MOFETIL mycophenolate mofetil SUSPENSION;ORAL 210370-001 Feb 12, 2019 AB RX No No   Start Trial   Start Trial
Vistapharm LACTULOSE lactulose SOLUTION;ORAL 074138-001 Sep 30, 1992 AA RX No No   Start Trial   Start Trial
Vistapharm PREDNISOLONE prednisolone SYRUP;ORAL 040323-001 May 13, 1999 AA RX No No   Start Trial   Start Trial
Vistapharm HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate SOLUTION;ORAL 200343-001 Jan 25, 2012 AA RX No No   Start Trial   Start Trial
Vistapharm METHADONE HYDROCHLORIDE methadone hydrochloride TABLET;ORAL 040241-002 May 29, 1998 AA RX No No   Start Trial   Start Trial
Vistapharm MORPHINE SULFATE morphine sulfate SOLUTION;ORAL 201947-001 Jan 5, 2012 DISCN No No   Start Trial   Start Trial
Vistapharm METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride SOLUTION;ORAL 075051-001 Jan 26, 2001 AA RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Colorcon
Dow
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.